Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for TLRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
May 31, 2026 68.44M
February 28, 2026 -4.315M
November 30, 2025 47.55M
August 31, 2025 19.85M
May 31, 2025 18.77M
February 28, 2025 15.05M
November 30, 2024 38.03M
August 31, 2024 60.59M
May 31, 2024 7.910M
February 29, 2024 -11.98M
November 30, 2023 -84.51M
August 31, 2023 14.02M
May 31, 2023 6.312M
February 28, 2023 -2.136M
November 30, 2022 -58.74M
August 31, 2022 123.62M
Date Value
May 31, 2022 160.26M
February 28, 2022 -5.206M
November 30, 2021 -19.89M
August 31, 2021 -8.028M
December 31, 2020 59.66M
September 30, 2020 50.15M
June 30, 2020 3.018M
March 31, 2020 159.79M
December 31, 2019 69.86M
September 30, 2019 39.75M
June 30, 2019 4.942M
March 31, 2019 0.744M
December 31, 2018 442.40M
September 30, 2018 121.43M
June 30, 2018 1.555M
March 31, 2018 53.91M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
SNDL, Inc. -24.11M
cbdMD, Inc. -0.0597M
Clearmind Medicine, Inc. 4.653M
CannaPharmaRx, Inc. 0.1824M
Cosmos Health, Inc. 1.863M